A feasibility study of the efficacy and tolerability of the combination of Exemestane with the COX-2 inhibitor Celecoxib in post-menopausal patients with advanced breast cancer. [electronic resource]
Producer: 20070109Description: 2751-6 p. digitalISSN:- 0959-8049
- Adult
- Aged
- Androstadienes -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Breast Neoplasms -- drug therapy
- Celecoxib
- Cyclooxygenase 2 Inhibitors -- administration & dosage
- Disease-Free Survival
- Feasibility Studies
- Female
- Humans
- Middle Aged
- Postmenopause
- Pyrazoles -- administration & dosage
- Quality of Life
- Sulfonamides -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.